ConditionSystemic Sclerosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Brest
About this trial
This study corresponds to a monocentric prospective cohort of adult patients with systemic sclerosis.
It will allow the constitution of an organized collection of longitudinal clinical data as well as collection of biological samples, including blood samples, as well as stool sample and skin swab for microbiota analysis.
Eligibility criteria
Qualifiers
Major patient with systemic sclerosis defined according to the EULAR 2013 criteria (see Appendix 1)
Patient evaluated within the framework of the reference center for rare autoimmune diseases of the CHU of Brest.
Patient affiliated to the social security system
Patient having signed a written informed consent.
Disqualifiers
Minor
Patient under legal protection (guardianship, curatorship)
Refusal to participate
Patient unable to consent
Trial design
Treatments tested in this trial
- Blood samples
- Stool samples
- Skin swab samples
- Questionnaires on quality of life, pain and disability
- Skin biopsies
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov